Idioma: Inglés
Publicado por Academic Press Inc 2013-11-12, 2013
ISBN 10: 0124046312 ISBN 13: 9780124046313
Librería: Chiron Media, Wallingford, Reino Unido
EUR 70,51
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardcover. Condición: New.
EUR 83,79
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 220.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 79,64
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 1st edition. 220 pages. 9.00x6.25x0.75 inches. In Stock.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 95,86
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 220 Index 1st Edition.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 93,96
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 220.
Idioma: Inglés
Publicado por Elsevier Science Publishing Co Inc, 2013
ISBN 10: 0124046312 ISBN 13: 9780124046313
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 89,38
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
Librería: ChouetteCoop, Kervignac, Francia
EUR 63,64
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Used: Good. Occasion - Bon Etat - Benign & pathological chromosomal imbalances (2013) - Grand Format.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 70,21
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Elsevier Science Sep 2013, 2013
ISBN 10: 0124046312 ISBN 13: 9780124046313
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 74,95
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Benign & Pathological Chromosomal Imbalances systematically clarifies the disease implications of cytogenetically visible copy number variants (CG-CNV) using cytogenetic assessment of heterochromatic or euchromatic DNA variants. While variants of several megabasepair can be present in the human genome without clinical consequence, visually distinguishing these benign areas from disease implications does not always occur to practitioners accustomed to costly molecular profiling methods such as FISH, aCGH, and NGS. As technology-driven approaches like FISH and aCGH have yet to achieve the promise of universal coverage or cost efficacy to sample investigated, deep chromosome analysis and molecular cytogenetics remains relevant for technology translation, study design, and therapeutic assessment. Knowledge of the rare but recurrent rearrangements unfamiliar to practitioners saves time and money for molecular cytogeneticists and genetics counselors, helping to distinguish benign from harmful CG-CNV. It also supports them in deciding which molecular cytogenetics tools to deploy. 220 pp. Englisch.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 80,80
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Benign & Pathological Chromosomal Imbalances systematically clarifies the disease implications of cytogenetically visible copy number variants (CG-CNV) using cytogenetic assessment of heterochromatic or euchromatic DNA variants. While variants of several megabasepair can be present in the human genome without clinical consequence, visually distinguishing these benign areas from disease implications does not always occur to practitioners accustomed to costly molecular profiling methods such as FISH, aCGH, and NGS. As technology-driven approaches like FISH and aCGH have yet to achieve the promise of universal coverage or cost efficacy to sample investigated, deep chromosome analysis and molecular cytogenetics remains relevant for technology translation, study design, and therapeutic assessment. Knowledge of the rare but recurrent rearrangements unfamiliar to practitioners saves time and money for molecular cytogeneticists and genetics counselors, helping to distinguish benign from harmful CG-CNV. It also supports them in deciding which molecular cytogenetics tools to deploy.